Inventor · disambiguated record
David Lonergan
Also filed as: LONERGAN DAVID · LONERGAN DAVID G · LONERGAN DAVID GREGORY
24 granted patents·5 pending applications·75 citations·filing 2004–2023
94Inventor score
Top patents by PatentIndex Score
29 records- 0194US11344533B2Autotaxin inhibitor compoundsSABRE THERAPEUTICS LLC·Filed 2020·Granted May 31, 2022·3 cites·19 claims
- 0293US9334261B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2015·Granted May 10, 2016·9 cites·17 claims
- 0392US11779568B2Autotaxin inhibitor compoundsSABRE THERAPEUTICS LLC·Filed 2022·Granted Oct 10, 2023·1 cites·35 claims
- 0492US10688081B2Autotaxin inhibitor compoundsSABRE THERAPEUTICS LLC·Filed 2018·Granted Jun 23, 2020·4 cites·19 claims
- 0592US9468628B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2016·Granted Oct 18, 2016·7 cites·15 claims
- 0690US9999615B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2016·Granted Jun 19, 2018·6 cites·20 claims
- 0790US7858666B2IRE-1α inhibitorsMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·13 cites·24 claims
- 0889US7312330B2Bicycloheteroarylamine compounds as ion channel ligands and uses thereofRENOVIS INC·Filed 2005·Granted Dec 25, 2007·8 cites·38 claims
- 0988US10774069B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2017·Granted Sep 15, 2020·2 cites·9 claims
- 1088US10766860B2Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2016·Granted Sep 8, 2020·4 cites·11 claims
- 1188US10632104B2Autotaxin inhibitors and uses thereofSABRE THERAPEUTICS LLC·Filed 2016·Granted Apr 28, 2020·4 cites·9 claims
- 1286US12268668B2Autotaxin inhibitor compoundsSABRE THERAPEUTICS LLC·Filed 2023·Granted Apr 8, 2025·0 cites·18 claims
- 1384US8614253B2IRE-1α inhibitorsPATTERSON JOHN BRUCE·Filed 2010·Granted Dec 24, 2013·7 cites·56 claims
- 1481US9926318B2Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2014·Granted Mar 27, 2018·4 cites·17 claims
- 1574US9241942B2IRE-1α inhibitorsMANNKIND CORP·Filed 2013·Granted Jan 26, 2016·1 cites·57 claims
- 1671US9546149B2IRE-1α inhibitorsMANNKIND CORP·Filed 2015·Granted Jan 17, 2017·1 cites·6 claims
- 1768US9951026B2Heterocyclic vinyl autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Apr 24, 2018·1 cites·19 claims
- 1862US11358936B2Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2020·Granted Jun 14, 2022·0 cites·11 claims
- 1960US11459309B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2020·Granted Oct 4, 2022·0 cites·5 claims
- 2060US9981901B2IRE-1α inhibitorsFOSUN ORINOVE PHARMATECH INC·Filed 2016·Granted May 29, 2018·0 cites·2 claims
- 2157US12458627B2Autotaxin inhibitors and uses thereofDF 2024 IP Acquisition LLC·Filed 2020·Granted Nov 4, 2025·0 cites·15 claims
- 2253US2023382891A1Glutaminyl-peptide cyclotransferase like (qpctl) protein inhibitors and uses thereofBLACKSMITH MEDICINES INC·Filed 2021·Application pending·0 cites
- 2350US2018162859A1Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2018·Application pending·0 cites
- 2448US7414131B2Bicycloheteroarylamine compounds as ion channel ligands and uses thereofRENOVIS INC·Filed 2004·Granted Aug 19, 2008·0 cites·7 claims
- 2546US9850203B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Dec 26, 2017·0 cites·20 claims
- 2646US9714240B2Vinyl autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Jul 25, 2017·0 cites·22 claims
- 2744US2010022531A1Novel compounds as p2x7 modulators and uses thereofRENOVIS INC·Filed 2006·Application pending·0 cites
- 2836US2017088520A1Deubiquitinase inhibitorsPHARMAKEA INC·Filed 2015·Application pending·0 cites
- 2935US2017095457A1Compositions and methods of delivery of deubiquitinase inhibitorsLONERGAN DAVID·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →